Inflammation and complications of HIV disease

Journal of Infectious Diseases

Volumn 201, Issue 12, 2010, Pages 1783-1785

  Dubé, Michael P ^a   Sattler, Fred R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; CD70 ANTIGEN; D DIMER; HIGH SENSITIVITY C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; SOLUBLE CD40 LIGAND; SOLUBLE CD70 ANTIGEN; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALPHALIPOPROTEINEMIA; IMMUNOSURVEILLANCE; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MUSCLE ATROPHY; NEOPLASM; NOTE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REMISSION; SUBCUTANEOUS FAT DISORDER; VIRUS LOAD; VIRUS REPLICATION; AIDS RELATED COMPLEX; B CELL LYMPHOMA; ENDOTHELIUM; HIV ASSOCIATED DEMENTIA; HIV ASSOCIATED LIPODYSTROPHY; PATHOLOGY;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BLOOD COAGULATION DISORDERS; ENDOTHELIUM; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INFLAMMATION; LYMPHOMA, AIDS-RELATED;

EID: 77952569909     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652751     Document Type: Note

References (12)

1. Torriani FJ, Komarow L, Parker RA, et al. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 2008; 52:569-576.
2. Riddler SA, Li X, Chu H, et al. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy. HIV Med 2007; 8:280-287. (Pubitemid 46901526)
3. DAD Study Group, Friis-Moller N, Reiss P, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735. (Pubitemid 46658704)
4. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201(12):1788-1795 (in this issue).
5. Kalayjian RC, Machekano RN, Rizk N, et al. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis 2010201(12):1796-1805 (in this issue).
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in appatently healthy men. N Engl J Med 1997; 336:973-979 (erratum: N Engl J Med 1997; 337:356).
7. Danesh J, Kaptoge S, Mann AG, et al Long term interleukin 6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5:e78.
8. Kuller LH, Tracy R, Belloso W, et aL Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
9. Gandhi RT, Spritzler J, Chan E, et aL Effect of baseline and treatment related factors on immunologic recovery after initiation of an tiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr AIDS 2006; 42:426-434. (Pubitemid 44050889)
10. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Investig 2001; 107:143-151. (Pubitemid 32096827)
11. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
12. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune res loralion in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.